Skip to main content
Eurostyle Collection Lisboa Table Lamp by Gilt <img src="https://chart.googleapis.com/chart?cht=qr&chs=200x200&chl=https%3A%2F%2Fapi.shopstyle.com%2Faction%2FapiVisitRetailer%3Fid%3D687775003%26pid%3Duid1456-40284116-11%26utm_content%3Dqr-code">
Post a Comment

ALL ABOUT MS Treatment (Part 12)

ALL ABOUT MS  Treatment (Part 12)

The influence of infections and vaccination on the progression of multiple sclerosis


Infections that most often contribute to the deterioration of multiple sclerosis are in most cases of viral infection of the upper respiratory tract. Multiple sclerosis sufferers have two to three times the risk of exacerbating the disease if they are infected with viruses, causing these infections. In several recent studies, 30% of the worsening of the disease has been reported to occur in periods when respiratory infections are current. However, this does not mean that any viral infection will result in the deterioration of multiple sclerosis. In addition to viral infections, infectious agents such as chlamydia pneumoniae and mycoplasma pneumoniae can also contribute to the worsening of the disease.

In addition to general measures of protection against infections such as nutrition rich in vitamins and minerals, avoiding groups and staying in unprotected spaces, the best protection against infections provides immunization with appropriate vaccines. The most commonly used vaccine against respiratory infections is the influenza vaccine.


In the past years there were significant dilemmas about the immunization of patients with multiple sclerosis. Namely, having in mind that multiple sclerosis is an immune-mediated disease, the question arises as to whether additional stimulation of the already damaged immune system can contribute to its inappropriate response and lead to a worsening of the disease. However, after large and very sophisticated epidemiological and clinical studies conducted in France and the United States involving a large number of subjects, it has been shown that for people suffering from multiple sclerosis, it is useful to vaccinate the influenza vaccine. It is also known that the vaccine does not represent absolute protection against influenza, but the clinical picture of the influenza vaccine is much milder and, as a rule, there are no complications. In this way, in patients with multiple sclerosis, the risk of deterioration of the underlying disease is significantly reduced.
Labels:

Comments

Post a Comment

Popular posts from this blog

ALL ABOUT MS Treatment (Part 10)

ALL ABOUT MS  Treatment (Part 10) Physical treatment The most important goals of physiotherapy in MS patients are to alleviate the existing symptoms of the disease in the form of pain, fatigue, muscle spasms and urinary tract, to improve and preserve mobility at the highest possible level, and to enable daily activities, self-care , professional activity and social contacts. In MS, the use of electrotherapy (electrostimulation, drug electrophoresis, diadynamic currents, interferent currents, transcutaneous electromechanical stimulation), magnetotherapy, laser therapy, hydrotherapy (swimming, exercise, massage), kinesitherapy (exercise), work therapy and primary aids function. Exposure to heat can lead to deterioration of the symptoms of the disease, and it is therefore prohibited to use those physical agents that create heat in the body, e.g. high-frequency current KTD. Also, pool water in hydrotherapy should not be warmer than 29 o C. In MS patients, reha...
Post a Comment
Read more

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS  Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...
Post a Comment
Read more

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...
Post a Comment
Read more